Filing Details
- Accession Number:
- 0001237899-12-000074
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-04 13:22:12
- Reporting Period:
- 2012-08-31
- Filing Date:
- 2012-09-04
- Accepted Time:
- 2012-09-04 13:22:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1226435 | A Murray Goldberg | 777 Old Saw Mill River Road Tarrytown NY 10591 | Svp Finance And Admin Cfo Trea | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-07-27 | 600 | $0.00 | 95,810 | No | 5 | G | Direct | |
Common Stock | Disposition | 2012-08-31 | 503 | $144.59 | 95,307 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-08-31 | 2,691 | $145.60 | 92,616 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-08-31 | 1,626 | $146.37 | 90,990 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-08-31 | 476 | $147.21 | 90,514 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 5,560 | Indirect | By 401(k) Plan |
Footnotes
- Gift of Common Stock to charitable organization.
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 503 shares of Company stock on August 31, 2012 at prices ranging from $144.00 to $144.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2012 at each separate price.
- Represents volume-weighted average price of sales of 2,691 shares of Company stock on August 31, 2012 at prices ranging from $145.03 to $145.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2012 at each separate price.
- Represents volume-weighted average price of sales of 1,626 shares of Company stock on August 31, 2012 at prices ranging from $146.06 to $146.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2012 at each separate price.
- Represents volume-weighted average price of sales of 476 shares of Company stock on August 31, 2012 at prices ranging from $147.10 to $147.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2012 at each separate price.